Zunsemetinib

Zunsemetinib (ATI-450) is an orally active and selective inhibitor of the p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway.Zunsemetinib is used to study spondyloarthritis and rheumatoid arthritis.

Product Specifications

CAS Number

1640282-42-3

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

513.92

Molecular Formula

C25H22ClF2N5O3

Notes

Research use only, not for human use.

Receptor

MAPK

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

AMM13502V 100 µL

SAPK4 (MAPK13) Mouse Monoclonal Antibody [Clone ID: LBI2G1]

Ask

View Details

C-935-100-100mg 100 mg

Chlorsulfuron

Ask

View Details

TRC-G615703-1G 1 g

Glycidol (~90%)

Ask

View Details

PH33059M5 20 µg

Glycogenin 2 (GYG2) (NM_001184703) Human Recombinant Protein

Ask

View Details